Rocket Pharmaceuticals
Rare Disease Therapeutics · Cell & Gene Therapy
Overview
Rocket Pharmaceuticals is a clinical-stage biotechnology company focused on developing first-in-class gene and cell therapies for rare, devastating genetic diseases. Headquartered in Cranbury, New Jersey, the firm advances an innovative pipeline of adeno-associated virus and lentiviral vector platforms targeting severe hematologic and cardiovascular disorders. By pioneering curative genetic treatments for high-unmet-need conditions, it aims to transform the lives of pediatric and adult patients suffering from rare illnesses worldwide.
Jobs
≈ $168k – $293k per year (Estimated) · Equity · In office · 5+ years exp · PhD · Cranbury
JMP
Analytics
Microsoft Excel
Life Sciences
PCR
ELISA
HPLC
GMP
Apply
$196k – $261k per year · Equity · In office · 12+ years exp · Bachelor's Degree · United States
Machine Learning
Apply
$118k – $158k per year · Equity · In office · 8+ years exp · Bachelor's Degree · Cranbury
Smartsheet
SharePoint
Life Sciences
GMP
LIMS
MedTech
CAPA
Apply
Salary insights
Compensation ranges based on this company's open jobs
Median
$146k
Typical range
$81k – $261k
Open positions
4
4
Jobs
Junior
25%
Senior
50%
Architect
25%
| Level | Jobs | Median | Typical range |
|---|---|---|---|
| Junior | 1 | $81k | $81k |
| Senior | 2 | $146k | $133k – $158k |
| Architect | 1 | $261k | $261k |
Highest paying role
Director, Business Insights & Analytics
$261k
Normalized to USD per year
Visa sponsorship
2 ▲ 100%
H-1B filings in 12 months
$193k
Median offered salary
3
Open roles in United States
Who they sponsor
Marketing managers
1
Project management specialists
1
In the register as Rocket Pharmaceuticals, Inc., Cranbury, NJ
Other sponsors in the same field
Vertex Pharmaceuticals 174 filings
Alnylam 36 filings
Sarepta 11 filings
Intellia Therapeutics 8 filings
See 3 open roles Alert me
US Department of Labor · latest filing Apr 9, 2026 · Visa details by country
Growth
Hiring Momentum
53/100
Stable
Open positions
6
1 opened / 3 closed in 30 days
Median time-to-fill
16 days
faster than 64% of the market
ATS activity
Every ~5 hours
Today
Hiring Dynamics
0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Finance
20%
Industrial Engineering
20%
Leadership
10% ▼
Support
10% ▼
Management
10% ▲
Marketing
10% ▼
Activity Timeline
Added PCR to stack
Oct 2026
Added JMP to stack
Oct 2026
Added HPLC to stack
Oct 2026
Added ELISA to stack
Oct 2026
Added Veeva to stack
Oct 2026
Added CAPA to stack
Oct 2026
Added 21 CFR Part 11 to stack
Oct 2026
Added LIMS to stack
Oct 2026
Added GMP to stack
Oct 2026
New location: United States
Oct 2026
+5 jobs in a week
Sep 2026
Tech stack
Technologies named in job postings at Rocket Pharmaceuticals over the last 12 months, by layer, with the share of postings for each.
Technologies in use
25
Postings analysed
7
Stack modernity
62/100
Languages
PowerShell
Cloud & platforms
Active Directory
Microsoft Entra ID
Okta
Windows
Sign in to see how your skills match this stack
Sign In
Full Rocket Pharmaceuticals tech stack
25 technologies · by team · pay by technology · changes · similar stacks
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Broadview VenturesVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Rocket Pharmaceuticals' FDA Decision Clears 'Meaningful Regulatory Overhang,' Says Needham - Sees 150% Upside Potential In RCKT Stock
Needham said the FDA outcome was better than expected because the regulator could have demanded meaningful changes to Rocket's Danon disease trial.
Read more
Report
Rocket Pharmaceuticals Announces FDA Alignment on Path to Complete Pivotal Phase 2 Trial of RP-A501 in Danon Disease
Read more
Report
Report
Rocket Pharmaceuticals Announces Positive Clinical Safety Update from Initial Three Patients Treated with RP-A501 Under Modified Phase 2 Protocol for Danon Disease
Read more
Report
Rocket Pharmaceuticals Announces Closing of Sale of Rare Pediatric Disease Priority Review Voucher for $180 Million
Read more
Report
Rocket Pharmaceuticals Pulls FDA Filing for Rare Blood Disorder Gene Therapy
Rocket Pharmaceuticals voluntarily withdrew the FDA submission for its Fanconi anemia gene therapy. The move follows a corporate restructuring over the summer that refocused the company on its cardiovascular programs.
Read more
Report
Rocket Pharmaceuticals, Inc. (RCKT) Investors Who Lost Money - Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Law Offices of Howard G. Smith announces an investigation on behalf of Rocket Pharmaceuticals, Inc. (
Read more
Report
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
Cranbury
Cranbury
United States
HQ
Rocket Pharmaceuticals, Inc.
5 open roles 9 posted in 90 days $124k Avg Salary
hires for Finance, Operations, Industrial Engineering
9 Cedarbrook Drive, Cranbury, NJ 08512